Fortive Corporation
FTV
$58.36
-3.10%
Fortive Corporation is a diversified industrial technology firm that provides essential technologies, software, and services globally across industries such as manufacturing, utilities, medical, and electronics. The company operates as a market leader in its niche through two primary segments: Intelligent Operating Solutions, which generates the majority of revenue from brands like Fluke and Accruent, and Advanced Healthcare Solutions. The current investor narrative centers on the company's ability to navigate a challenging revenue environment, as evidenced by a recent year-over-year decline, while simultaneously demonstrating margin resilience and cash generation, positioning it as a potential steady performer in an uncertain economic climate.…
FTV
Fortive Corporation
$58.36
Investment Opinion: Should I buy FTV Today?
Rating & Thesis: Hold. Fortive presents a conflicted profile of strong profitability and cash generation offset by severe revenue headwinds and a valuation that already prices in a recovery, making the risk/reward balanced at current levels. The lack of a clear analyst consensus and the recent Mizuho downgrade to 'Underperform' underscore the uncertainty.
Supporting Evidence: The recommendation is grounded in four key data points: 1) The severe 30.7% YoY revenue decline creates fundamental uncertainty, 2) The forward P/E of 17.6x is reasonable and implies a significant earnings rebound, 3) Exceptional profitability metrics (63.2% gross margin, 16.5% net margin) provide a defensive moat, and 4) Strong free cash flow of $978.1 million TTM supports the balance sheet and shareholder returns. The stock trades at a premium to its sector on a trailing basis (30.2x P/E) but is more in line on a forward basis.
Risks & Conditions: The two biggest risks are a continuation of the revenue decline and a failure to achieve the earnings implied by the forward P/E. This Hold rating would upgrade to a Buy if quarterly revenue growth turns positive or stabilizes, providing evidence the downturn is cyclical. It would downgrade to a Sell if revenue decline accelerates beyond -10% sequentially or if the forward P/E expands above 20x without corresponding earnings growth. The stock is currently fairly valued relative to its forward earnings potential but carries an overvaluation risk on trailing metrics.
Sign up to view all
FTV 12-Month Price Forecast
The outlook for FTV is one of high uncertainty balanced by defensive financial strengths. The core investment thesis hinges entirely on the trajectory of revenue. The base case (60% probability) of a slow, grinding recovery is most likely, given the company's market-leading positions and profitability. However, the bear case risk is material, as another disappointing quarter could swiftly invalidate the forward earnings narrative. The bull case requires a clear inflection point in demand that has not yet appeared. The stance would upgrade to bullish on concrete evidence of revenue stabilization (e.g., two consecutive quarters of flat or positive sequential growth). It would turn bearish if revenue declines accelerate or margins begin to compress meaningfully.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Fortive Corporation's 12-month outlook, with a consensus price target around $75.87 and implied upside of +30.0% versus the current price.
Average Target
$75.87
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$47 - $76
Analyst target range
Analyst coverage for Fortive is limited, with only 6 analysts providing estimates, indicating this is not a widely followed large-cap name. The available data shows consensus estimates for EPS and revenue but does not provide a consensus price target or recommendation distribution. This lack of broad coverage can lead to higher volatility and less efficient price discovery, as the stock is less scrutinized by the institutional investment community. Without a consensus price target or a clear buy/hold/sell breakdown, it is challenging to gauge analyst sentiment quantitatively. The recent institutional rating actions show a pattern of stability or cautiousness, with firms like Morgan Stanley, Barclays, and Wells Fargo maintaining 'Equal Weight' or equivalent ratings. Notably, Mizuho downgraded the stock from 'Outperform' to 'Underperform' in early January 2026, which aligns with the observed price weakness and may reflect concerns over the revenue trajectory or valuation.
Bulls vs Bears: FTV Investment Factors
The investment debate for Fortive is a classic battle between deteriorating fundamentals and resilient profitability. The bear case is strongly supported by the severe 30.7% YoY revenue decline, which is a concrete and alarming data point. The bull case rests on the company's impressive ability to maintain high margins (63.2% gross, 16.5% net) and generate nearly $1 billion in annual free cash flow despite this top-line pressure. Currently, the bear side has stronger evidence due to the magnitude and persistence of the revenue decline, which is the primary driver of stock valuation. The single most important tension is whether this revenue contraction is a cyclical trough or a structural decline. If it's the former, the current forward P/E of 17.6x could prove cheap. If it's the latter, even the strong margins may not protect the elevated trailing valuation from compression.
Bullish
- Exceptional Profitability & Margins: Despite a 30.7% YoY revenue decline in Q4 2025, Fortive maintained a robust gross margin of 63.2% and a net margin of 16.5%. This demonstrates significant pricing power and operational discipline, allowing the company to generate strong cash flow even in a downturn.
- Strong Free Cash Flow Generation: The company's trailing twelve-month free cash flow is $978.1 million, providing ample liquidity for shareholder returns and strategic investments. This cash generation, supported by a moderate debt-to-equity ratio of 0.50, significantly reduces financial risk.
- Attractive Forward Valuation: Fortive's forward P/E of 17.6x is substantially lower than its trailing P/E of 30.2x, implying the market expects a significant earnings recovery. This forward multiple is more in line with sector averages, suggesting the stock is not egregiously overvalued on a forward-looking basis.
- Relative Market Outperformance: Over the past six months, FTV has gained 11.25% while the S&P 500 (SPY) declined 2.0%, showing strong relative strength. This outperformance, with a 3-month relative strength of 5.25%, indicates investor confidence in its resilience despite top-line weakness.
Bearish
- Severe Revenue Contraction: Q4 2025 revenue of $1.12 billion represents a dramatic 30.7% year-over-year decline. This sharp contraction, following a multi-quarter downtrend, signals significant challenges in the company's core markets and raises questions about its near-term growth trajectory.
- Elevated Trailing Valuation: A trailing P/E of 30.2x is high for an industrial technology company, especially one experiencing a revenue decline. This premium multiple, which is above its historical range, leaves little room for error and suggests the market has already priced in a full recovery.
- Negative Analyst Sentiment Shift: Mizuho's recent downgrade from 'Outperform' to 'Underperform' in January 2026 aligns with the stock's recent price weakness and reflects growing concerns. With only 6 analysts covering the stock, such negative actions can have an outsized impact on sentiment.
- Technical Momentum Breakdown: The stock is down 3.36% over the past month and has retreated from its 52-week high of $62.42 to trade at $56.08. This loss of momentum, coupled with a 1-year price change of only 0.17%, suggests bullish conviction is waning and a period of consolidation or decline may be ahead.
FTV Technical Analysis
The stock is in a sustained uptrend over the past six months, with a price gain of 11.25%, but this masks a more volatile recent performance. Currently trading at $56.08, the price sits approximately 69% of its 52-week range ($45.50 to $62.42), indicating it is positioned in the upper-mid range, having retreated significantly from its highs. This positioning suggests the stock has lost some momentum after a strong run and may be consolidating before its next directional move. Recent momentum shows a clear deceleration and divergence from the longer-term trend; the stock is down 3.36% over the past month, contrasting with its positive 1.25% return over three months. This negative short-term momentum, coupled with a 1-year price change of only 0.17%, signals a potential loss of bullish conviction and a period of consolidation or profit-taking following the earlier advance. Key technical levels are the 52-week high of $62.42, which represents major resistance, and the 52-week low of $45.50, which serves as critical support. A breakout above $62.42 would signal a resumption of the uptrend, while a breakdown below $45.50 would indicate a more profound bearish shift. With a beta of 1.001, the stock's volatility is virtually identical to the broader market, suggesting its price movements are largely driven by sector and company-specific factors rather than amplified market swings.
Beta
1.00
1.00x market volatility
Max Drawdown
-20.0%
Largest decline past year
52-Week Range
$46-$62
Price range past year
Annual Return
+21.4%
Cumulative gain past year
| Period | FTV Return | S&P 500 |
|---|---|---|
| 1m | +3.6% | +0.5% |
| 3m | +6.1% | -2.1% |
| 6m | +22.1% | +4.0% |
| 1y | +21.4% | +29.5% |
| ytd | +5.4% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FTV Fundamental Analysis
Fortive's revenue trajectory shows signs of pressure, with Q4 2025 revenue of $1.12 billion representing a year-over-year decline of 30.7%. This sharp drop follows a multi-quarter trend of declining top-line figures from the prior year's comparable periods, indicating a significant slowdown or contraction in its core markets. Segment data reveals that the Intelligent Operating Solutions segment, at $808 million, remains the dominant revenue driver, but the overall decline suggests challenges across the portfolio. The company remains profitable with a Q4 2025 net income of $185.7 million, translating to a healthy net margin of 16.5%. Gross margin for the quarter was a robust 63.2%, and the trailing twelve-month operating margin stands at 17.7%, indicating strong underlying profitability despite revenue headwinds. The margin profile demonstrates the company's ability to maintain pricing power and cost discipline even in a softer demand environment. Fortive exhibits a solid balance sheet and strong cash generation, with a debt-to-equity ratio of 0.50 and a trailing twelve-month free cash flow of $978.1 million. The current ratio of 0.71 suggests a relatively tight liquidity position, but the substantial free cash flow, which supports shareholder returns via dividends and buybacks, indicates the company generates more than enough cash to fund operations and its capital allocation strategy internally, reducing financial risk.
Quarterly Revenue
$1.1B
2025-12
Revenue YoY Growth
-0.30%
YoY Comparison
Gross Margin
+0.63%
Latest Quarter
Free Cash Flow
$978100000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FTV Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. Fortive's trailing PE ratio is 30.2x, while its forward PE is notably lower at 17.6x. This significant gap implies the market expects a substantial recovery in earnings over the next twelve months, pricing in the anticipated improvement from current depressed levels. Compared to sector averages, Fortive's trailing PE of 30.2x is elevated, but the forward multiple of 17.6x is more in line with typical industrial technology valuations. The premium on the trailing multiple reflects the market's focus on normalized future earnings rather than the depressed current earnings impacted by the revenue decline. Historically, the stock's own trailing PE has fluctuated significantly; the current 30.2x is above the multi-year range observed in the historical data, which has often been in the low-to-mid 20s. Trading near the top of its historical PE band suggests the market is already pricing in a successful earnings recovery and margin stability, leaving limited room for multiple expansion unless growth accelerates beyond current expectations.
PE
30.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~73x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Fortive's primary risk is its significant revenue decline of 30.7% YoY, which, if sustained, would severely pressure earnings and call into question its growth narrative. While margins are currently robust, a prolonged downturn could lead to operating deleverage and margin contraction. The company's current ratio of 0.71 indicates a relatively tight liquidity position, though this is mitigated by its strong free cash flow generation of $978.1 million TTM. The elevated trailing P/E of 30.2x creates valuation risk if the expected earnings recovery fails to materialize.
Market & Competitive Risks: Trading at a trailing P/E of 30.2x, Fortive carries a valuation compression risk, especially if growth stock multiples contract in a higher-rate environment. Its beta of 1.001 means it moves in lockstep with the market, offering no volatility dampening during downturns. The stock has significantly underperformed the S&P 500 over the past year (FTV +0.17% vs. SPY +22.2%), indicating sector or company-specific headwinds that may persist. Competitive pressures in its industrial technology niches could intensify, further challenging revenue growth.
Worst-Case Scenario: The worst-case scenario involves the Q4 revenue decline marking the start of a structural, not cyclical, downturn. This would trigger multiple compression as the forward earnings recovery thesis unravels, leading to analyst downgrades and institutional selling. Combined with a broader market downturn, this could see the stock re-test its 52-week low of $45.50. From the current price of $56.08, this represents a potential downside of approximately -19%. A reversion to the lower end of its historical P/E range on depressed earnings could drive losses beyond this level.
FAQ
The key risks are, in order of severity: 1) Revenue Risk: The 30.7% YoY decline could continue or worsen, damaging the earnings recovery thesis. 2) Valuation Risk: The high trailing P/E of 30.2x could compress sharply if growth disappoints. 3) Sentiment Risk: With only 6 analysts, negative actions like Mizuho's recent downgrade can disproportionately impact the stock. 4) Market Risk: A beta of 1.001 means FTV offers no downside protection in a broad market sell-off. The company's strong cash flow and margins mitigate but do not eliminate these risks.
The 12-month forecast presents three scenarios. The base case (60% probability) sees the stock trading between $56 and $62, as the company shows slow progress stabilizing revenue. The bull case (25% probability) projects a move to $62-$68 on a clear return to revenue growth and earnings meeting the $4.39 EPS estimate. The bear case (15% probability) warns of a drop to the $45.50-$52.00 range if the revenue decline deepens. The base case is most likely, predicated on the assumption that the current downturn is cyclical and that Fortive's operational strengths will allow it to weather the storm, but a swift return to growth is not imminent.
FTV's valuation sends mixed signals. On a trailing basis, its P/E of 30.2x is elevated and suggests overvaluation, especially given the revenue decline. However, the forward P/E of 17.6x implies the market expects a substantial earnings rebound and is more in line with industrial sector averages, suggesting fair value. The key is that the stock is not cheap; it is fairly valued for a recovery that has not yet begun. The market is paying a premium for the company's high-quality margin profile and is discounting future normalized earnings, making it vulnerable if those earnings fail to materialize.
FTV is a Hold, not a clear-cut buy at its current price of $56.08. For investors with a high conviction that its 30.7% revenue decline is purely cyclical and temporary, the forward P/E of 17.6x and strong cash flow may represent a reasonable entry point. However, the severe top-line contraction and recent analyst downgrade introduce significant uncertainty. It could be a good buy for patient, value-oriented investors willing to wait 12-18 months for a recovery, but it carries the risk of further downside if the revenue weakness persists. The lack of a clear near-term catalyst suggests waiting for evidence of stabilization is prudent.
FTV is unsuitable for short-term trading due to its lack of near-term catalysts, recent negative momentum, and high uncertainty around quarterly results. It is better suited for a long-term investment horizon of 2-3 years, allowing time for its end markets to recover and for its earnings to converge with forward estimates. The stock's market-correlated volatility (beta 1.001) and minimal dividend yield (0.53%) do not support short-term income or trading strategies. Investors should be prepared to hold through potential further volatility while the company executes its turnaround.